219 related articles for article (PubMed ID: 18042220)
1. Haemoglobin-vesicles as artificial oxygen carriers: present situation and future visions.
Sakai H; Sou K; Horinouchi H; Kobayashi K; Tsuchida E
J Intern Med; 2008 Jan; 263(1):4-15. PubMed ID: 18042220
[TBL] [Abstract][Full Text] [Related]
2. Review of hemoglobin-vesicles as artificial oxygen carriers.
Sakai H; Sou K; Horinouchi H; Kobayashi K; Tsuchida E
Artif Organs; 2009 Feb; 33(2):139-45. PubMed ID: 19178458
[TBL] [Abstract][Full Text] [Related]
3. Artificial oxygen carriers, hemoglobin vesicles and albumin-hemes, based on bioconjugate chemistry.
Tsuchida E; Sou K; Nakagawa A; Sakai H; Komatsu T; Kobayashi K
Bioconjug Chem; 2009 Aug; 20(8):1419-40. PubMed ID: 19206516
[TBL] [Abstract][Full Text] [Related]
4. Performances of PEG-modified hemoglobin-vesicles as artificial oxygen carriers in microcirculation.
Sakai H; Tsuchida E
Clin Hemorheol Microcirc; 2006; 34(1-2):335-40. PubMed ID: 16543654
[TBL] [Abstract][Full Text] [Related]
5. Physiological capacity of the reticuloendothelial system for the degradation of hemoglobin vesicles (artificial oxygen carriers) after massive intravenous doses by daily repeated infusions for 14 days.
Sakai H; Masada Y; Horinouchi H; Ikeda E; Sou K; Takeoka S; Suematsu M; Takaori M; Kobayashi K; Tsuchida E
J Pharmacol Exp Ther; 2004 Dec; 311(3):874-84. PubMed ID: 15297471
[TBL] [Abstract][Full Text] [Related]
6. Hemoglobin vesicles, polyethylene glycol (PEG)ylated liposomes developed as a red blood cell substitute, do not induce the accelerated blood clearance phenomenon in mice.
Taguchi K; Urata Y; Anraku M; Watanabe H; Kadowaki D; Sakai H; Horinouchi H; Kobayashi K; Tsuchida E; Maruyama T; Otagiri M
Drug Metab Dispos; 2009 Nov; 37(11):2197-203. PubMed ID: 19679674
[TBL] [Abstract][Full Text] [Related]
7. Biocompatibility study of hemoglobin vesicles, cellular-type artificial oxygen carriers, with human umbilical cord hematopoietic stem/progenitor cells using an in vitro expansion system.
Yamaguchi M; Fujihara M; Wakamoto S; Sakai H; Takeoka S; Tsuchida E; Hamada H; Azuma H; Ikeda H
ASAIO J; 2009; 55(3):200-5. PubMed ID: 19282747
[TBL] [Abstract][Full Text] [Related]
8. Metabolism of hemoglobin-vesicles (artificial oxygen carriers) and their influence on organ functions in a rat model.
Sakai H; Horinouchi H; Masada Y; Takeoka S; Ikeda E; Takaori M; Kobayashi K; Tsuchida E
Biomaterials; 2004 Aug; 25(18):4317-25. PubMed ID: 15046922
[TBL] [Abstract][Full Text] [Related]
9. Hemoglobin-vesicles as an artificial oxygen carrier.
Sakai H; Sou K; Tsuchida E
Methods Enzymol; 2009; 465():363-84. PubMed ID: 19913177
[TBL] [Abstract][Full Text] [Related]
10. Liposome-Encapsulated Hemoglobin, TRM-645: Current Status of the Development and Important Issues for Clinical Application.
Kaneda S; Ishizuka T; Goto H; Kimura T; Inaba K; Kasukawa H
Artif Organs; 2009 Feb; 33(2):146-52. PubMed ID: 19178459
[TBL] [Abstract][Full Text] [Related]
11. Hepatically-metabolized and -excreted artificial oxygen carrier, hemoglobin vesicles, can be safely used under conditions of hepatic impairment.
Taguchi K; Miyasato M; Ujihira H; Watanabe H; Kadowaki D; Sakai H; Tsuchida E; Horinouchi H; Kobayashi K; Maruyama T; Otagiri M
Toxicol Appl Pharmacol; 2010 Nov; 248(3):234-41. PubMed ID: 20709091
[TBL] [Abstract][Full Text] [Related]
12. Hemoglobin-vesicles as a transfusion alternative.
Tsuchida E; Sakai H; Horinouchi H; Kobayashi K
Artif Cells Blood Substit Immobil Biotechnol; 2006; 34(6):581-8. PubMed ID: 17090430
[TBL] [Abstract][Full Text] [Related]
13. Hemoglobin vesicles and red blood cells as carriers of carbon monoxide prior to oxygen for resuscitation after hemorrhagic shock in a rat model.
Sakai H; Horinouchi H; Tsuchida E; Kobayashi K
Shock; 2009 May; 31(5):507-14. PubMed ID: 18827742
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetic study of enclosed hemoglobin and outer lipid component after the administration of hemoglobin vesicles as an artificial oxygen carrier.
Taguchi K; Urata Y; Anraku M; Maruyama T; Watanabe H; Sakai H; Horinouchi H; Kobayashi K; Tsuchida E; Kai T; Otagiri M
Drug Metab Dispos; 2009 Jul; 37(7):1456-63. PubMed ID: 19364827
[TBL] [Abstract][Full Text] [Related]
15. Polymer/hemoglobin assemblies: biodegradable oxygen carriers for artificial red blood cells.
Li T; Jing X; Huang Y
Macromol Biosci; 2011 Jul; 11(7):865-75. PubMed ID: 21312333
[TBL] [Abstract][Full Text] [Related]
16. Fluid resuscitation with artificial oxygen carriers in hemorrhaged rats: profiles of hemoglobin-vesicle degradation and hematopoiesis for 14 days.
Sakai H; Seishi Y; Obata Y; Takeoka S; Horinouichi H; Tsuchida E; Kobayashi K
Shock; 2009 Feb; 31(2):192-200. PubMed ID: 18520699
[TBL] [Abstract][Full Text] [Related]
17. Acute 40 percent exchange-transfusion with hemoglobin-vesicles (HbV) suspended in recombinant human serum albumin solution: degradation of HbV and erythropoiesis in a rat spleen for 2 weeks.
Sakai H; Horinouchi H; Yamamoto M; Ikeda E; Takeoka S; Takaori M; Tsuchida E; Kobayashi K
Transfusion; 2006 Mar; 46(3):339-47. PubMed ID: 16533274
[TBL] [Abstract][Full Text] [Related]
18. One-year observation of Wistar rats after intravenous infusion of hemoglobin-vesicles (artificial oxygen carriers).
Sakai H; Tsuchida E; Horinouchi H; Kobayashi K
Artif Cells Blood Substit Immobil Biotechnol; 2007; 35(1):81-91. PubMed ID: 17364473
[TBL] [Abstract][Full Text] [Related]
19. Modern oxygen carriers: state of art 1990.
Rudowski W
Mater Med Pol; 1990; 22(1):3-7. PubMed ID: 2079858
[TBL] [Abstract][Full Text] [Related]
20. Hemoglobin-vesicles as oxygen carriers: influence on phagocytic activity and histopathological changes in reticuloendothelial system.
Sakai H; Horinouchi H; Tomiyama K; Ikeda E; Takeoka S; Kobayashi K; Tsuchida E
Am J Pathol; 2001 Sep; 159(3):1079-88. PubMed ID: 11549600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
